HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA: Registrants Using Skin Sensitization Alt Methods Should Update Dossiers Using OECD 497

Executive Summary

The agency is aware of more than 14,000 substances on the EU market with some indication of skin-sensitization concern. Using the OECD guideline, adopted in June, registrants may be able to make conclusive predictions without use of animals and should update REACH dossiers accordingly.

You may also be interested in...



EU REACH Analysis Corroborates Animal Welfare View: Testing Continues For Cosmetics-Only Ingredients

A multi-stakeholder analysis of REACH data revealed that while animal testing of cosmetic ingredients dropped dramatically after March 2013 when the Cosmetic Products Regulation’s marketing ban on animal-tested ingredients was fully implemented, the practice did not cease altogether.

ICCVAM Plans For Alternative Skin-Sensitization Tests

The Interagency Coordinating Committee on the Validation of Alternative Test Methods says it is developing a plan to help it evaluate and advance alternative tests for skin sensitization at a time when skin allergies are a growing concern.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151861

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel